4:55 PM
 | 
Jul 24, 2014
 |  BC Extra  |  Financial News

Immune Design, Pfenex price IPOs

Cancer immunotherapy company Immune Design Corp. (NASDAQ:IMDZ) and biosimilar play Pfenex Inc. (NYSE-M:PFNX) priced their IPOs on Thursday. Immune Design raised $60 million through the sale of a bumped-up number of shares at the low end of its proposed range. Immune Design sold 5 million shares at $12, which values the company at $190.5 million. Last week, the...

Read the full 278 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >